Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

The current state of funded NIH grants in implementation science in genomic medicine: a portfolio analysis.

Roberts MC, Clyne M, Kennedy AE, Chambers DA, Khoury MJ.

Genet Med. 2019 May;21(5):1218-1223. doi: 10.1038/gim.2017.180. Epub 2017 Oct 26.

PMID:
31048814
2.

The Role of Host Genetic Polymorphisms in Helicobacter pylori Mediated Disease Outcome.

Clyne M, Rowland M.

Adv Exp Med Biol. 2019 Apr 24. doi: 10.1007/5584_2019_364. [Epub ahead of print]

PMID:
31016623
3.

Using deep learning to identify translational research in genomic medicine beyond bench to bedside.

Hsu YY, Clyne M, Wei CH, Khoury MJ, Lu Z.

Database (Oxford). 2019 Jan 1;2019. doi: 10.1093/database/baz010.

4.

Resident bacteria in breast cancer tissue: pathogenic agents or harmless commensals?

O'Connor H, MacSharry J, Bueso YF, Lindsay S, Kavanagh EL, Tangney M, Clyne M, Saldova R, McCann A.

Discov Med. 2018 Sep;26(142):93-102. Review.

5.

HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders.

Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ.

Genet Med. 2019 Mar;21(3):519-524. doi: 10.1038/s41436-018-0118-1. Epub 2018 Sep 10. Review.

PMID:
30197419
6.

Binding of Helicobacter pylori to Human Gastric Mucins Correlates with Binding of TFF1.

Dunne C, Naughton J, Duggan G, Loughrey C, Kilcoyne M, Joshi L, Carrington S, Earley H, Backert S, Robbe Masselot C, May FEB, Clyne M.

Microorganisms. 2018 May 18;6(2). pii: E44. doi: 10.3390/microorganisms6020044.

7.

Proposed outcomes measures for state public health genomic programs.

Doyle DL, Clyne M, Rodriguez JL, Cragun DL, Senier L, Hurst G, Chan K, Chambers DA.

Genet Med. 2018 Sep;20(9):995-1003. doi: 10.1038/gim.2017.229. Epub 2018 Jan 4.

8.

From public health genomics to precision public health: a 20-year journey.

Khoury MJ, Bowen MS, Clyne M, Dotson WD, Gwinn ML, Green RF, Kolor K, Rodriguez JL, Wulf A, Yu W.

Genet Med. 2018 Jun;20(6):574-582. doi: 10.1038/gim.2017.211. Epub 2017 Dec 14. Review.

9.

The current state of funded NIH grants in implementation science in genomic medicine: a portfolio analysis.

Roberts MC, Clyne M, Kennedy AE, Chambers DA, Khoury MJ.

Genet Med. 2017 Oct 26. doi: 10.1038/gim.2017.180. [Epub ahead of print]

10.

The use of stool specimens reveals Helicobacter pylori strain diversity in a cohort of adolescents and their family members in a developed country.

Dolan B, Burkitt-Gray L, Shovelin S, Bourke B, Drumm B, Rowland M, Clyne M.

Int J Med Microbiol. 2018 Mar;308(2):247-255. doi: 10.1016/j.ijmm.2017.11.005. Epub 2017 Nov 13.

11.

Long-term follow-up of the incidence of Helicobacter pylori.

Rowland M, Clyne M, Daly L, O'Connor H, Bourke B, Bury G, O'Dowd T, Connolly L, Ryan J, Shovlin S, Dolan B, Drumm B.

Clin Microbiol Infect. 2018 Sep;24(9):980-984. doi: 10.1016/j.cmi.2017.10.020. Epub 2017 Oct 28.

PMID:
29107816
12.

Glycosylation-related gene expression in HT29-MTX-E12 cells upon infection by Helicobacter pylori.

Cairns MT, Gupta A, Naughton JA, Kane M, Clyne M, Joshi L.

World J Gastroenterol. 2017 Oct 7;23(37):6817-6832. doi: 10.3748/wjg.v23.i37.6817.

13.

Use of Recombinant Mucin Glycoprotein to Assess the Interaction of the Gastric Pathogen Helicobacter pylori with the Secreted Human Mucin MUC5AC.

Dunne C, McDermot A, Anjan K, Ryan A, Reid C, Clyne M.

Bioengineering (Basel). 2017 Apr 15;4(2). pii: E34. doi: 10.3390/bioengineering4020034.

14.

Directing iron transport in dicots: regulation of iron acquisition and translocation.

Jeong J, Merkovich A, Clyne M, Connolly EL.

Curr Opin Plant Biol. 2017 Oct;39:106-113. doi: 10.1016/j.pbi.2017.06.014. Epub 2017 Jul 6. Review.

PMID:
28689052
15.

Peer Education Versus Computer-Based Education: Improve Utilization of Library Databases Among Direct Care Nurses.

Gonzalez R, O'Brien-Barry P, Ancheta R, Razal R, Clyne ME.

J Nurses Prof Dev. 2017 Jul/Aug;33(4):E1-E5. doi: 10.1097/NND.0000000000000371.

PMID:
28683041
16.

Erratum to: Assays to Study the Interaction of Campylobacter jejuni with the Mucosal Surface.

Clyne M, Duggan G, Dunne C, Dolan B, Alvarez L, Bourke B.

Methods Mol Biol. 2017;1512:E1. doi: 10.1007/978-1-4939-6536-6_22. No abstract available.

PMID:
28190242
17.

Trends in published meta-analyses in cancer research, 2008-2013.

Qadir XV, Clyne M, Lam TK, Khoury MJ, Schully SD.

Cancer Causes Control. 2017 Jan;28(1):5-12. doi: 10.1007/s10552-016-0830-6. Epub 2016 Nov 29.

18.

Assays to Study the Interaction of Campylobacter jejuni with the Mucosal Surface.

Clyne M, Duggan G, Dunne C, Dolan B, Alvarez L, Bourke B.

Methods Mol Biol. 2017;1512:129-147. Erratum in: Methods Mol Biol. 2017;1512:E1.

PMID:
27885604
19.

Methods to Assess the Direct Interaction of C. jejuni with Mucins.

Clyne M, Duggan G, Naughton J, Bourke B.

Methods Mol Biol. 2017;1512:107-115.

PMID:
27885602
20.

A knowledge base for tracking the impact of genomics on population health.

Yu W, Gwinn M, Dotson WD, Green RF, Clyne M, Wulf A, Bowen S, Kolor K, Khoury MJ.

Genet Med. 2016 Dec;18(12):1312-1314. doi: 10.1038/gim.2016.63. Epub 2016 Jun 9.

21.

A Preliminary Study Examining the Binding Capacity of Akkermansia muciniphila and Desulfovibrio spp., to Colonic Mucin in Health and Ulcerative Colitis.

Earley H, Lennon G, Balfe A, Kilcoyne M, Clyne M, Joshi L, Carrington S, Martin ST, Coffey JC, Winter DC, O'Connell PR.

PLoS One. 2015 Oct 22;10(10):e0135280. doi: 10.1371/journal.pone.0135280. eCollection 2015.

22.

Expression and characterization of a novel recombinant version of the secreted human mucin MUC5AC in airway cell lines.

Ryan A, Smith A, Moore P, McNally S, Carrington SD, Reid CJ, Clyne M.

Biochemistry. 2015 Feb 3;54(4):1089-99. doi: 10.1021/bi5011267. Epub 2015 Jan 16.

PMID:
25559041
23.

The Cancer Genomics and Epidemiology Navigator: An NCI online tool to enhance cancer epidemiology research.

Schully SD, Rogers SD, Lam TK, Chang CQ, Clyne M, Cyr J, Watson D, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2610-1. doi: 10.1158/1055-9965.EPI-14-0902. No abstract available.

24.

Prostate cancer: metformin--the new wonder drug?

Clyne M.

Nat Rev Urol. 2014 Jul;11(7):366. doi: 10.1038/nrurol.2014.136. Epub 2014 Jun 10. No abstract available.

PMID:
24914783
25.

Factors that mediate colonization of the human stomach by Helicobacter pylori.

Dunne C, Dolan B, Clyne M.

World J Gastroenterol. 2014 May 21;20(19):5610-24. doi: 10.3748/wjg.v20.i19.5610. Review.

26.

Paediatrics: antimicrobial prophylaxis for vesicoureteral reflux-where will the RIVUR study lead us?

Clyne M.

Nat Rev Urol. 2014 Jun;11(6):301. doi: 10.1038/nrurol.2014.112. Epub 2014 May 20. No abstract available.

PMID:
24841170
27.

Paediatrics: dipstick adequate for febrile UTI test.

Clyne M.

Nat Rev Urol. 2014 Jun;11(6):304. doi: 10.1038/nrurol.2014.116. Epub 2014 May 20. No abstract available.

PMID:
24841169
28.

Prostate cancer: combined FEC-PET/MRI improves diagnostic accuracy.

Clyne M.

Nat Rev Urol. 2014 Jun;11(6):306. doi: 10.1038/nrurol.2014.111. Epub 2014 May 13. No abstract available.

PMID:
24818855
29.

Bladder cancer: faster recovery after radical cystectomy with alvimopan.

Clyne M.

Nat Rev Urol. 2014 Apr;11(4):186. doi: 10.1038/nrurol.2014.67. Epub 2014 Mar 18. No abstract available.

PMID:
24637421
30.

Prostate cancer: cabozantinib reduces pain and narcotic use in men with CRPC.

Clyne M.

Nat Rev Urol. 2014 Apr;11(4):188. doi: 10.1038/nrurol.2014.57. Epub 2014 Mar 11. No abstract available.

PMID:
24619377
31.

Bladder cancer: Potentially fewer minor complications with RARC than ORC but at what cost?

Clyne M.

Nat Rev Urol. 2014 Mar;11(3):130. doi: 10.1038/nrurol.2014.44. Epub 2014 Feb 25. No abstract available.

PMID:
24567087
32.

Prostate cancer: What is the real IMPACT of BRCA1/BRCA2 mutation?

Clyne M.

Nat Rev Urol. 2014 Mar;11(3):124. doi: 10.1038/nrurol.2014.19. Epub 2014 Feb 4. No abstract available.

PMID:
24492431
33.

Tipping the balance in favour of degarelix for ADT.

Clyne M.

Nat Rev Urol. 2014 Feb;11(2):67. doi: 10.1038/nrurol.2014.11. Epub 2014 Jan 28. No abstract available.

PMID:
24473414
34.

Should we give metformin to all men with CRPC?

Clyne M.

Nat Rev Urol. 2014 Feb;11(2):63. doi: 10.1038/nrurol.2014.7. Epub 2014 Jan 21. No abstract available.

PMID:
24445914
35.

Horizon scanning for translational genomic research beyond bench to bedside.

Clyne M, Schully SD, Dotson WD, Douglas MP, Gwinn M, Kolor K, Wulf A, Bowen MS, Khoury MJ.

Genet Med. 2014 Jul;16(7):535-8. doi: 10.1038/gim.2013.184. Epub 2014 Jan 9.

36.

Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.

Dotson WD, Douglas MP, Kolor K, Stewart AC, Bowen MS, Gwinn M, Wulf A, Anders HM, Chang CQ, Clyne M, Lam TK, Schully SD, Marrone M, Feero WG, Khoury MJ.

Clin Pharmacol Ther. 2014 Apr;95(4):394-402. doi: 10.1038/clpt.2013.226. Epub 2014 Feb 19. Review.

37.

The difference between men and women.

Clyne M.

Nat Rev Urol. 2014 Feb;11(2):66. doi: 10.1038/nrurol.2013.316. Epub 2013 Dec 24. No abstract available.

PMID:
24366348
38.

Can PDE5 inhibitors boost brain function?

Clyne M.

Nat Rev Urol. 2014 Feb;11(2):65. doi: 10.1038/nrurol.2013.309. Epub 2013 Dec 17. No abstract available.

PMID:
24346005
39.

Prostate cancer: Open vs laparoscopic vs robotic RP-the biggest study to date.

Clyne M.

Nat Rev Urol. 2014 Jan;11(1):6. doi: 10.1038/nrurol.2013.306. Epub 2013 Dec 10. No abstract available.

PMID:
24323129
40.

Prostate cancer: Visual estimation versus software fusion for MRI-targeted biopsy.

Clyne M.

Nat Rev Urol. 2014 Jan;11(1):5. doi: 10.1038/nrurol.2013.285. Epub 2013 Dec 3. No abstract available.

PMID:
24296702
41.

Prostate cancer: Cardiovascular morbidity risk lower for ADT with GnRH antagonists than GnRH agonists.

Clyne M.

Nat Rev Urol. 2013 Dec;10(12):679. doi: 10.1038/nrurol.2013.268. Epub 2013 Nov 19. No abstract available.

PMID:
24247426
42.

Copper promotes TFF1-mediated Helicobacter pylori colonization.

Montefusco S, Esposito R, D'Andrea L, Monti MC, Dunne C, Dolan B, Tosco A, Marzullo L, Clyne M.

PLoS One. 2013 Nov 13;8(11):e79455. doi: 10.1371/journal.pone.0079455. eCollection 2013.

43.

Kidney cancer: Low serum sodium linked to poor outcomes for patients with mRCC treated with targeted therapy.

Clyne M.

Nat Rev Urol. 2013 Dec;10(12):679. doi: 10.1038/nrurol.2013.264. Epub 2013 Nov 12. No abstract available.

PMID:
24217674
44.

The kids are alright.

Clyne M.

Nat Rev Urol. 2013 Nov;10(11):613. doi: 10.1038/nrurol.2013.247. No abstract available.

PMID:
24197089
45.

Prostate cancer: Non-O blood type is VTE risk factor after radical prostatectomy.

Clyne M.

Nat Rev Urol. 2013 Dec;10(12):680. doi: 10.1038/nrurol.2013.255. Epub 2013 Nov 5. No abstract available.

PMID:
24189930
46.

Interaction of microbes with mucus and mucins: recent developments.

Naughton J, Duggan G, Bourke B, Clyne M.

Gut Microbes. 2014 Jan-Feb;5(1):48-52. doi: 10.4161/gmic.26680. Epub 2013 Oct 2.

47.

Paediatric urology: cuff-only AUS for refractory neurogenic incontinence.

Clyne M.

Nat Rev Urol. 2013 Nov;10(11):619. doi: 10.1038/nrurol.2013.235. Epub 2013 Oct 15. Review. No abstract available.

PMID:
24126729
48.

Paediatric urology: invasive management needed for failed pyeloplasty?

Clyne M.

Nat Rev Urol. 2013 Nov;10(11):620. doi: 10.1038/nrurol.2013.224. Epub 2013 Oct 1. No abstract available.

PMID:
24080905
49.

Kidney cancer: predicting survival after targeted therapy for mRCC.

Clyne M.

Nat Rev Urol. 2013 Oct;10(10):554. doi: 10.1038/nrurol.2013.205. Epub 2013 Sep 3. No abstract available.

PMID:
23999581
50.

Bladder cancer: aristolochic acid--one of the most potent carcinogens known to man.

Clyne M.

Nat Rev Urol. 2013 Oct;10(10):552. doi: 10.1038/nrurol.2013.186. Epub 2013 Aug 27. No abstract available.

PMID:
23979661

Supplemental Content

Support Center